Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 44Esophageal Squamous Cell Carcinoma 18Carcinoma, Squamous Cell 5Neoplasms 3Sarcopenia 2Radiation Injuries 2Adenocarcinoma 2Stomach Neoplasms 1Respiratory Insufficiency 1Radiation Pneumonitis 1Radiation Fibrosis Syndrome 1Pulmonary Fibrosis 1Postoperative Complications 1Pneumonia 1Pathologic Complete Response 1Pain, Postoperative 1Osteoporosis 1Obesity, Abdominal 1Obesity 1Neoplastic Cells, Circulating 1Motor Activity 1Margins of Excision 1Loco-regional Esophageal Cancer 1Esophageal Diseases 1Deglutition Disorders 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Brain Neoplasms 1Barrett Esophagus 1Anastomotic Leak 1Adenocarcinoma Of Esophagus 1

Interventions

Fluorouracil 67Radiotherapy 53Cisplatin 52Oxaliplatin 47Leucovorin 37Paclitaxel 36Irinotecan 27Docetaxel 23Capecitabine 20Nivolumab 17Carboplatin 16pembrolizumab 15Radiation 15Neoadjuvant Therapy 15Surgical Procedures, Operative 12Cetuximab 12durvalumab 9Drug Therapy 9Biopsy 9Taxes 8Folfox protocol 8Chemotherapy, Adjuvant 8Trastuzumab 7Magnetic Resonance Spectroscopy 7Gefitinib 7Endoscopy 7tremelimumab 6Specimen Handling 6Endoscopy, Digestive System 6Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Esophagectomy × Gastrointestinal × Clear all
NCT03223662 2018-10-30

Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
2 enrolled 6 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡